¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26
±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇѼҾƽÉÀåÇÐȸ
´ã´çÀÚ : ¼ÛÁø¿µ
¿¬¶ôó : 02-3410-0647  
À̸ÞÀÏ : pediheart@pediheart.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ (50,000) Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ (40,000) Çлý(¹«·á)      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:00~14:20 Nitric oxide revisit including iNOmax  Çϱâ¼ö(°í´ë±¸·Î º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:20~14:40 Riociguat in the pediatric population and clinical application  Á¤Á¶¿ø(¼¼ºê¶õ½º º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:40~15:00 IV Epoprestenol, preparation to use  ¾È°æÁø(±æ º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:00~15:20 Pulmonary vasodilator in Fontan patient, update  ±è±â¹ü(¼­¿ï´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:20~15:40 Korean pulmonary hypertension guideline review  Â÷½½±â(¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 03¿ù 26ÀÏ ¿Â¶óÀΠ15:40~16:00 Åä·Ð  () 
È޽Ġ03¿ù 26ÀÏ  16:00~16:20 È޽Ġ () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:20~16:30 Overcome of pulmonary hypertension applying BiPAP for infant with lung hypoplasia  ±è¿©Çâ(°æºÏ´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:30~16:40 ±¸¿¬2  °¡°­»ç(¼­¿ï¼º¸ð º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:40~16:50 ±¸¿¬3  ³ª°­»ç(¼­¿ï¾Æ»ê º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:50~17:00 ±¸¿¬4  ´Ù°­»ç(¼¼ºê¶õ½º º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ17:00~17:10 Successful treatment of subcutaneous treprostinil for pulmonary hypertension with bronchopulmonary dysplasia in an extremely premature infant  °íÈÆ(¾ç»ê ºÎ»ê´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ17:10~17:20 ±¸¿¬6  ¶ó°­»ç(¼¼Á¾ º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦21ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ È£³²Áöȸ ÇмúÁý´ãȸ : 2021-03-27
´ÙÀ½±Û ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) Á¦242Â÷ °æºÏÁöȸ Áý´ãȸ : 2021-03-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 35 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 25 2024-06-18
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 42 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 9 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 44 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 30 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 17 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 17 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 41 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 43 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 34 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 47 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 25 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 21 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 17 2024-06-18
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷